Israel's ProSpecBio launches Activin-A recombinant protein for brain injury research

Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global resea...

October 13, 2025 | Monday | News
Roche collaborates with OASES to strengthen Hong Kong's position as global healthcare hub

Roche has announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelera...

October 13, 2025 | Monday | News
Korea's Samsung Biologics introduces optimised manufacturing framework ExellenS™

South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has unveiled ...

October 10, 2025 | Friday | News
Gunze Medical and HistoSonics enter into distribution agreement in Japan for non-invasive ultrasound therapy devices

Gunze Limited has announced that its wholly owned subsidiary, Gunze Medical Limited and US-based HistoSonics, Inc. have ...

October 10, 2025 | Friday | News
Japan's Alpha Fusion and Kobe City Medical Center General Hospital establish At-211 investigational drug supply system

Japan's startup Alpha Fusion Inc. has announced a joint initiative with the Kobe City Medical Center General Hospital (K...

October 9, 2025 | Thursday | News
Taiwan's Lotus Pharma to commercialise Semaglutide injection for obesity in multiple Asian markets

Taiwan based Lotus Pharmaceutical, a leading global pharmaceutical company, has entered into a License and Supply Agreem...

October 8, 2025 | Wednesday | News
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA

UK-based Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, and its long-standing partner Celltrion In...

October 8, 2025 | Wednesday | News
RedHill Biopharma signs $1.8 M deal to accelerate Talicia's entry into new Middle East markets

RedHill Biopharma, a US-based specialty biopharmaceutical company, has announced the licensing of Talicia for new Middle...

October 7, 2025 | Tuesday | News
Lupin invests $250 M to build new state-of-the-art manufacturing facility in US

Global pharmaceutical leader Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant...

October 9, 2025 | Thursday | News
Japan's Kubota to introduce myopia management device in Thailand

Japanese pharmaceutical company Kubota Pharmaceutical Holdings Co., Ltd. will introduce Thailand to its ground...

October 7, 2025 | Tuesday | News
Agilent and Chungnam National University to build Open Biopharma Research Hub in South Korea

Agilent Technologies Inc. has recently announced a strategic partnership with Chungnam National University&nbs...

October 3, 2025 | Friday | News
Japan's Daiichi Sankyo establishes third research institute in US

Japanese pharmaceutical firm Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, US represent...

October 3, 2025 | Friday | News
South Korea's Boryung to acquire global rights to Taxotere from Sanofi for €175 M

South Korea's Boryung Corporation has signed an asset purchase agreement with the global biopharma company Sanofi to acq...

October 6, 2025 | Monday | News
AbbVie begins construction on $70 M expansion to increase biologics manufacturing and R&D presence in US

AbbVie has announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in...

October 1, 2025 | Wednesday | News
Fosun Pharma deepens global layout with new office in Jeddah, Saudi Arabia

The inauguration ceremony for the Fosun Pharma Middle East Office and Fosunhenlius Middle East United Company was recent...

October 1, 2025 | Wednesday | News
Australia's Cell Therapies partners with Teijin to expand access to advanced cell and gene therapies in Japan and APAC region

Australia-based Cell Therapies and Japan's Teijin Limited have signed a Memorandum of Understanding ...

October 1, 2025 | Wednesday | News
Hong Kong's Health Hope Pharma enters into virology deal with Gilead Sciences

Health Hope Pharma (HHP), a clinical-stage oncology biopharma company headquartered in Hong Kong, has entered into ...

September 30, 2025 | Tuesday | News
Lantheus divests rights of prostate cancer PET tracer in Japan to GE HealthCare

Lantheus Holdings, Inc. and GE HealthCare have announced an exclusive licensing agreement for GE HealthCare to develop, ...

September 30, 2025 | Tuesday | News